US 11,964,249 B2
Milk protein concentrate-based microencapsulation wall material and microcapsules
Peng Zhou, Wuxi (CN); Jinhua Hu, Wuxi (CN); Fengchen Zhuang, Wuxi (CN); Xiang Li, Wuxi (CN); Yuejie Jin, Wuxi (CN); Chaoyue Zhang, Wuxi (CN); Minjun Cheng, Wuxi (CN); and Yongxue Liang, Wuxi (CN)
Assigned to JIANGNAN UNIVERSITY, Wuxi (CN)
Filed by Jiangnan University, Wuxi (CN)
Filed on Dec. 16, 2020, as Appl. No. 17/123,415.
Application 17/123,415 is a continuation of application No. PCT/CN2018/095876, filed on Jul. 17, 2018.
Claims priority of application No. 201810677817.0 (CN), filed on Jun. 27, 2018.
Prior Publication US 2021/0101126 A1, Apr. 8, 2021
Int. Cl. B01J 13/04 (2006.01); A23J 3/08 (2006.01); B01D 15/36 (2006.01); B01F 23/41 (2022.01); B01F 23/80 (2022.01)
CPC B01J 13/04 (2013.01) [B01D 15/361 (2013.01); B01F 23/4105 (2022.01); B01F 23/804 (2022.01); B01F 23/809 (2022.01); A23J 3/08 (2013.01); B01F 23/413 (2022.01); B01F 23/4143 (2022.01)] 10 Claims
OG exemplary drawing
 
1. A microcapsule, comprising:
a wall material, and
a core material,
wherein the wall material comprises a pretreated milk protein concentrate (MPC),
wherein the core material comprises one or more of vitamins, unsaturated fatty acids, probiotics, vaccines, and essential oils; and
wherein the pretreated MPC is prepared by subjecting the MPC to any one or more of the following:
a) stirring ion exchange resin with the MPC,
b) adding an acid to the MPC, wherein the acid is selected from one or more of hydrochloric acid, sulfuric acid, acetic acid, and glucolactone, and then subjecting the MPC to ultrafiltration, and
c) adding a calcium ion chelator to the MPC, wherein the chelator is selected from one or more of ethylene diamine tetraacetic acid (EDTA), citric acid, malic acid, and tartrate.